Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary …
Y Zhao, Y Luo, Y Cheng, H Wang… - BMJ Open …, 2023 - bmjopenrespres.bmj.com
Background Extended oral anticoagulant (OA) use is recommended in patients with acute
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary …
Y Zhao, Y Luo, Y Cheng, H Wang… - BMJ open …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Extended oral anticoagulant (OA) use is recommended in patients with acute
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
[HTML][HTML] Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary …
Y Zhao, Y Luo, Y Cheng, H Wang, H Du… - BMJ Open …, 2023 - ncbi.nlm.nih.gov
Background Extended oral anticoagulant (OA) use is recommended in patients with acute
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary …
Y Zhao, Y Luo, Y Cheng, H Wang, H Du… - BMJ Open …, 2023 - europepmc.org
Background Extended oral anticoagulant (OA) use is recommended in patients with acute
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …
pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the …